Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma
Authors
Keywords
Disseminated tumor cells, Endometrial carcinoma, L1CAM, Risk classification, Prognosis
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 143, Issue 11, Pages 2183-2188
Publisher
Springer Nature
Online
2017-07-14
DOI
10.1007/s00432-017-2474-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer
- (2017) Mathieu P. Pelletier et al. HUMAN PATHOLOGY
- Second Opinion Expert Pathology in Endometrial Cancer
- (2017) Friederike Grevenkamp et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrium Cancer
- (2017) Muzaffer Sanci et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
- (2016) Louis JM van der Putten et al. BRITISH JOURNAL OF CANCER
- L1CAM is an independent predictor of poor survival in endometrial cancer — An analysis of The Cancer Genome Atlas (TCGA)
- (2016) Thanh H. Dellinger et al. GYNECOLOGIC ONCOLOGY
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
- (2016) Nicoletta Colombo et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- L1CAM: amending the “low-risk” category in endometrial carcinoma
- (2016) Felix Kommoss et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Early dissemination seeds metastasis in breast cancer
- (2016) Hedayatollah Hosseini et al. NATURE
- L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
- (2016) Yvette P. Geels et al. PATHOLOGY & ONCOLOGY RESEARCH
- L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
- (2014) T. Bosse et al. EUROPEAN JOURNAL OF CANCER
- Lymphovascular Space Invasion in Microcystic Elongated and Fragmented (MELF)-Pattern Well-differentiated Endometrioid Adenocarcinoma is Associated With a Higher Rate of Lymph Node Metastasis
- (2014) Johann D. Hertel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Unusual Patterns of Endometrial Carcinoma Including MELF and its Relation to Epithelial Mesenchymal Transition
- (2014) Richard J. Zaino INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Prevalence and prognostic value of disseminated tumor cells in primary endometrial, cervical and vulvar cancer patients
- (2013) Christina Barbara Walter et al. Future Oncology
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
- (2013) Alain G. Zeimet et al. JNCI-Journal of the National Cancer Institute
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- MELF invasion in endometrial cancer as a risk factor for lymph node metastasis
- (2011) Kitty Pavlakis et al. HISTOPATHOLOGY
- Disseminated Tumor Cells in Bone Marrow May Affect Prognosis of Patients With Gynecologic Malignancies
- (2010) Malgorzata Banys et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now